Biosimulation Market Size to Worth Around US$ 9.17 Bn by 2030
Ottawa, April 27, 2022 (GLOBE NEWSWIRE) -- The drug resistance characteristics of certain diseases like bacterial infections and cancer have resulted in the increased incidences of drug relapse. The rising investments by the biotechnology companies in the …